Tagamet and Blood amylase increased - a phase IV clinical study of FDA data

Summary:

Blood amylase increased is reported as a side effect among people who take Tagamet (cimetidine), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Nexavar, and have Renal cell carcinoma stage iv.

The phase IV clinical study analyzes which people have Blood amylase increased when taking Tagamet. It is created by eHealthMe based on reports of 8,789 people who have side effects when taking Tagamet from the FDA, and is updated regularly.

What is Tagamet?

Tagamet has active ingredients of cimetidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 9,011 Tagamet users. Check the latest studies of Tagamet.

What is Blood amylase increased?

Blood amylase increased is found to be associated with 458 drugs and 839 conditions by eHealthMe. Check the latest studies of Blood amylase increased.

On Aug, 07, 2026

8,789 people reported to have side effects when taking Tagamet.
Among them, 34 people (0.39%) have Blood amylase increased.

Could Tagamet cause Blood amylase increased?

Among these 34 people:

How long have people been on Tagamet when they have Blood amylase increased? *

What is the gender of people who have Blood amylase increased when taking Tagamet? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Blood amylase increased when taking Tagamet? *

What are other drugs people take besides Tagamet? *

What are other side effects people have besides Blood amylase increased? *

Lipase Increased: 23 people, 67.65%
High Blood Pressure: 21 people, 61.76%
Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 11 people, 32.35%
Hair Loss: 11 people, 32.35%
Rashes (redness): 9 people, 26.47%
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 6 people, 17.65%
Nausea (feeling of having an urge to vomit): 5 people, 14.71%
Diarrhea: 5 people, 14.71%
Pleural Effusion (water on the lungs): 5 people, 14.71%
Pain In Extremity: 5 people, 14.71%

What are the existing conditions these people have? *

Renal Cell Carcinoma Stage Iv (stage iv renal cell cancer have cancer that has spread to other organs, such as the lungs, liver, bones, or brain, and may have spread to lymph nodes): 17 people, 50.00%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 5 people, 14.71%
Gastritis (inflammation of stomach): 5 people, 14.71%
Enlarged Prostate: 5 people, 14.71%
Renal Cell Carcinoma (a kidney cancer): 4 people, 11.76%
Swollen Tongue (swelling of tongue): 1 person, 2.94%
Iron Overload: 1 person, 2.94%
Chronic Renal Failure (kidney failure): 1 person, 2.94%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 1 person, 2.94%
Breast Cancer Metastatic: 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Tagamet and have Blood amylase increased?

- Check whether Blood amylase increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tagamet:

Tagamet (9,011 reports)

Browse all side effects of Tagamet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blood amylase increased:

Blood amylase increased (458 drugs)

Browse all the conditions that are associated with Blood amylase increased:

Blood amylase increased (839 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cimetidine (the active ingredients of Tagamet) and Tagamet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.